Laboratory test kit and method for using the laboratory test kit
AssigneeBiomedical Research Institute Co., Ltd.
InventorsIsao MIYAZAKI, Kazumi HAGA, Kei HAGA
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiomedical Research Institute Co., Ltd.
InventorsIsao MIYAZAKI, Kazumi HAGA, Kei HAGA
Estimating the term…
A laboratory test kit includes a development part 12 for developing thereon a test sample containing a virus, reagent portion 13 and a recognition portion 17. On the recognition portion 17, first and second specific antibodies both derived from a mouse are to be immobilized for specifically recognizing first and second antigen-determining sites respectively both possessed by the virus. The reagent portion 13 includes first and second labeled antibodies both derived from a mouse, which specifically recognize the first and second antigen-determining sites respectively both possessed by the virus and are labeled with a labeling substance. In each of the first and second labeled antibodies, at least one of an antigen site which is recognized by the HAMA or a sugar chain binding site recognized by an antibody which recognizes a sugar chain is defected or modified.
A laboratory test kit used for diagnosing infection caused by a virus, comprising a development part for developing thereon a test sample containing the virus, a recognition portion provided in the middle of the development part, and a reagent portion disposed in contact with an edge portion of an upstream side of the development part when a developing direction in which the test sample is developed on the development part is taken as a reference, the recognition portion on which a first specific antibody and a second specific antibody both derived from a mouse are to be immobilized for specifically recognizing a first antigen-determining site and a second antigen-determining site both possessed by the virus, the reagent portion includes a first labeled antibody and a second labeled antibody both derived from a mouse, which have a function of specifically recognizing the first antigen-determining site and the second antigen-determining site both possessed by the virus and are labeled with a labeling substance, and in each of the first labeled antibody and the second labeled antibody, at least one of an antigen site which is recognized by a human anti-mouse antibody or a sugar chain binding site recognized by an antibody which recognizes a sugar chain is defected or modified.
Dependencies are inferred from the claim text.